Vitamin D to Improve Quadricep Muscle Strength

Recruiting Phase 2 Interventional Study
Anterior Cruciate Ligament Injuries Quadriceps Muscle Atrophy Anterior Cruciate Ligament Rupture Anterior Cruciate Ligament Tear
Prior Safety Data This treatment has already been tested in at least one earlier human trial.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 40
Sex
Any
Trial phase
Phase 2
Study type
Interventional
Purpose
Treatment
Participants needed
60 (estimated)
Sponsor
Chinese University of Hong Kong · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Quadriceps muscle strength is one of the key determinants for patients to fulfill the Return-to-Play (RTP) criteria after an anterior cruciate ligament reconstruction (ACLR), in which the muscle size is directly linked to muscle strength. Quadriceps muscle atrophy is unavoidable after ACLR, but the rehabilitation program should increase quadriceps muscle mass. However, despite good rehabilitation …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Aged 18-40 with unilateral ACL injury 2. Sporting injury with a Tegner score of 7 3. Pre-op serum vitamin D level \<20 ng/ml 4. 4 months post-ACLR with serum Vitamin D level remained \<20ng/ml 5. LSI for quadriceps strength \<70% of contralateral leg at 4-month isokinetic ass…
Contacts

Michael Tim-Yun Ong

26364171

michael.ong@cuhk.edu.hk

CONTACT